🇺🇸 FDA
Pipeline program

RILUTEK 50 mg film-coated tablets, masitinib, Placebo to 200mg masitinib, masitinib, Riluzole Zentiva 50 mg film-coated tablets, Placebo to 100mg masitinib

AB23005

Phase 3 small_molecule active

Quick answer

RILUTEK 50 mg film-coated tablets, masitinib, Placebo to 200mg masitinib, masitinib, Riluzole Zentiva 50 mg film-coated tablets, Placebo to 100mg masitinib for Amyotrophic Lateral Sclerosis is a Phase 3 program (small_molecule) at AB Science with 1 ClinicalTrials.gov record(s).

Program details

Company
AB Science
Indication
Amyotrophic Lateral Sclerosis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials